Hodgkin lymphoma in an individual with <i>TREX1</i>‐mediated Aicardi Goutières syndrome
Francesco Gavazzi(Children's Hospital of Philadelphia), Rebecca L. Linn(University of Pennsylvania), Miriam Bloom(Children's National), David T. Teachey(Children's Hospital of Philadelphia), Teresa Victoria(Children's Hospital of Philadelphia), Jullie Rhee(Children's National), Jamie L. Fraser(Children's National), Laura Tochen(Children's National), Megan Kwan(Children's Hospital of Philadelphia), Cheng‐Ying Ho, Adeline Vanderver(Children's Hospital of Philadelphia)
Cited by 3
Related Papers
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
|Cancer Cell|2012|722
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
|The Lancet Neurology|2020|326
T-cell acute lymphoblastic leukemia
|Hematology|2016|307